CUBE vs LYRA · P/E 25, rev $1.07B vs rev $1.5M
CubeSmart (CUBE) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the CUBE and LYRA stock pages for the full models.
Not investment advice.